Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 41

Results For "IDA"

1939 News Found

Eris Lifesciences reports Q4FY21 consolidated net profit of Rs. 68.24 Cr
News | May 13, 2021

Eris Lifesciences reports Q4FY21 consolidated net profit of Rs. 68.24 Cr

Eris Lifesciences has reported total income of Rs.1220.57 crores during the 12 months period ended March 31, 2021


Lupin reports Q4FY21 consolidated PAT of Rs. 460.36 Cr
News | May 13, 2021

Lupin reports Q4FY21 consolidated PAT of Rs. 460.36 Cr

It reported total income of Rs.15299.25 crores during the FY ended March 31, 2021


Zydus Wellness reports Rs. 133.13 Cr consolidated PAT in Q4FY21
News | May 10, 2021

Zydus Wellness reports Rs. 133.13 Cr consolidated PAT in Q4FY21

Glucon-D, Sugar Free, EverYuth Scrub, Peel Off Face Mask and Nycil maintained their leadership positions in-their respective categories as on March 2021.


Ajanta Pharma Q4FY21 consolidated PAT drops QoQ to Rs. 159.26 Cr
News | May 03, 2021

Ajanta Pharma Q4FY21 consolidated PAT drops QoQ to Rs. 159.26 Cr

The companyreported total income of Rs.2915.67 crores during the 12 months period ended March 31, 2021


SMS Pharmaceuticals Q3FY21 consolidated PAT up to Rs. 21.39 Cr
News | February 11, 2021

SMS Pharmaceuticals Q3FY21 consolidated PAT up to Rs. 21.39 Cr

The company posted net profit of Rs.7.61 crores for the period ended December 31, 2019.


J B Chemicals & Pharmaceuticals Q3FY 21 consolidated PAT up at Rs. 151.66 Cr
News | February 11, 2021

J B Chemicals & Pharmaceuticals Q3FY 21 consolidated PAT up at Rs. 151.66 Cr

The company posted net profit of Rs.62.17 crores for the period ended December 31, 2019.


Jubilant Pharmova Q3FY21 consolidated PAT at Rs. 309.93 Cr
News | February 08, 2021

Jubilant Pharmova Q3FY21 consolidated PAT at Rs. 309.93 Cr

The company posted net profit of Rs.203.38 crores for the period ended December 31, 2019.


Cadila Healthcare Q3FY21 consolidated PAT up at Rs. 527.2 Cr
News | February 06, 2021

Cadila Healthcare Q3FY21 consolidated PAT up at Rs. 527.2 Cr

The company's business in India geography posted strong growth during the quarter as it grew by 20% on a y-o-y basis and registered revenues of Rs. 1,643 crore.


GlaxoSmithKline Pharmaceuticals Q3FY21 consolidated PAT at Rs. 156.51 Cr
News | February 06, 2021

GlaxoSmithKline Pharmaceuticals Q3FY21 consolidated PAT at Rs. 156.51 Cr

The company posted net loss of Rs. 661.16 crores for the period ended December 31, 2019.


Zydus wellness reports 31% growth in net sales in Q2 FY26
News | November 06, 2025

Zydus wellness reports 31% growth in net sales in Q2 FY26

During the quarter, Zydus Wellness completed the acquisition of Comfort Click Limited and its subsidiaries